O'Dell Group’s Alaunos Therapeutics TCRT Stock Holding History

O'Dell Group’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-68	Closed	-$718	–	429
2023 Q4	$718	Hold	68	–	–	﹤0.01%	468
2023 Q3	$1.34K	Hold	68	–	–	﹤0.01%	79
2023 Q2	$5.17K	Hold	68	–	–	﹤0.01%	388
2023 Q1	$6.39K	Hold	68	–	–	﹤0.01%	70
2022 Q4	$6.58K	Hold	68	–	–	﹤0.01%	74
2022 Q3	$17K	Hold	68	–	–	0.01%	246
2022 Q2	$13K	Hold	68	–	–	﹤0.01%	265
2022 Q1	$7K	Hold	68	–	–	﹤0.01%	354
2021 Q4	$11K	Hold	68	–	–	﹤0.01%	297
2021 Q3	$18K	Hold	68	–	–	0.01%	246
2021 Q2	$27K	Hold	68	–	–	0.01%	80
2021 Q1	$37K	Hold	68	–	–	0.01%	71
2020 Q4	$26K	Buy	+68	New	+$27K	0.01%	66
2020 Q1	–	Sell	-68	Closed	-$48K	–	56
2019 Q4	$48K	Hold	68	–	–	0.02%	61
2019 Q3	$43K	Hold	68	–	–	0.02%	56
2019 Q2	$59K	Hold	68	–	–	0.04%	56
2019 Q1	$39K	Hold	68	–	–	0.02%	52
2018 Q4	$19K	Hold	68	–	–	0.01%	45
2018 Q3	$32K	Hold	68	–	–	0.02%	36
2018 Q2	$31K	Hold	68	–	–	0.02%	41
2018 Q1	$40K	Hold	68	–	–	0.03%	39
2017 Q4	$42K	Hold	68	–	–	0.03%	42
2017 Q3	$62K	Hold	68	–	–	0.05%	35
2017 Q2	$63K	Hold	68	–	–	0.05%	33
2017 Q1	$64K	Hold	68	–	–	0.06%	31
2016 Q4	$54K	Buy	+68	New	+$61.3K	0.05%	32

Other funds holding TCRT

MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

Allred Capital Management Dallas, Texas $305M AUM 26.92% 1-Year Est. Return

O'Dell Group's TCRT Position: Q1 2024 in Review

O'Dell Group sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 68 shares — an estimated $718 sold.

O'Dell Group first reported a position in TCRT in Q4 2016 and held it in 26 quarters. The position peaked at $64K in Q1 2017. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

O'Dell Group reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
O'Dell Group sold 68 Alaunos Therapeutics shares in Q1 2024, an estimated $718.
O'Dell Group first reported a position in Alaunos Therapeutics in Q4 2016 and held it in 26 quarters.
O'Dell Group's Alaunos Therapeutics position peaked at $64K in Q1 2017.
45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.